user

Real-world experience of dacomitinib in mEGFR Advanced NSCLC: A single centre experience

被引：0
|
作者：
Biswas, B. [1 ]
Ganguly, S. [1 ]
Ghosh, J. [1 ]
Roy, S. [1 ]
Bhattacharjee, A. [1 ]
Bakshi, R. [1 ]
机构：
[1] TMC Tata Med Ctr, Dept Med Oncol, Kolkata, India
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2372
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1339P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-world experience of dacomitinib in EGFR mutated advanced NSCLC: A single center experience from India.
    Biswas, Bivas
    Ganguly, Sandip
    Ghosh, Joydeep
    Roy, Somnath
    Bakshi, Rupsa
    Dabkara, Deepak
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Real-world experience with nivolumab and atezolizumab toxicities in advanced thoracic malignancies: a single centre experience in the UK
    Choy, J.
    Chang, Y.
    Newsom-Davis, T.
    [J]. LUNG CANCER, 2019, 127 : S69 - S70
  • [3] Real-World Experience Favors a Neoadjuvant Strategy of Chemoimmunotherapy for Locoregionally Advanced NSCLC
    Kneuertz, Peter J.
    [J]. ANNALS OF THORACIC SURGERY, 2024, 118 (03): : 681 - 682
  • [4] Sacubitril-Valsartan: real-world single-centre experience
    Climent, Herminio Morillas
    Lopez, Alvaro Vicedo
    Moya, Julia Seller
    Torres, Edgard Alania
    Jornet, Emilio Galcera
    Rodriguez, Ainhoa Larumbe
    Piles, Carlos Nunez
    Munoz, Alfonso Valle
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 257 - 257
  • [5] Lipid lowering with inclisiran: a real-world single-centre experience
    Padam, Pritpal
    Barton, Lucy
    Wilson, Stewart
    David, Alessia
    Walji, Shahenaz
    de Lorenzo, Ferruccio
    Ray, Kausik K.
    Jones, Ben
    Cegla, Jaimini
    [J]. OPEN HEART, 2022, 9 (02):
  • [6] Real World Experience with Chemoradiotherapy in Locally Advanced NSCLC
    Gimeno, Joaquin
    Torres, Irene
    Hernando, Jorge
    Comin, Ana
    Pajares, Isabel
    Puertas, Mar
    Felices, Pilar
    Nuno, Ana
    Lao, Juan
    Artal Cortes, Angel
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S856 - S856
  • [7] Real-world experience in advanced NSCLC using FDA approved NGS CDx.
    Elkhouly, Ehab
    Zhou, Li
    Kurtis, Boaz
    Wang, Lan
    Israyelyan, Anna
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] LOREALAUS: LOrlatinib REAL-World AUStralian Experience in Advanced ALK-Rearranged NSCLC
    Alexander, Marliese
    Wei, Joe
    Parakh, Sagun
    John, Thomas
    Kao, Steven
    Nagrial, Adnan
    Bowyer, Samantha
    Warburton, Lydia
    Moore, Melissa
    Hughes, Brett G. M.
    Clay, Timothy D.
    Pavlakis, Nick
    Solomon, Benjamin J.
    Itchins, Malinda
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (04):
  • [9] Lorlatinib in advanced ALK-rearranged NSCLC - real-world experience in a UK population
    Lucas, Tylan
    Hassan, Heba
    Sattar, Alisha
    So, Alfred
    Buckley, Thomas
    Hunter, Sarah
    Masento, Sebastian
    Naureen, Sofia
    Benafif, Sarah
    Boleti, Ekaterina
    Tarver, Kathryn
    Ahmad, Tanya
    Newsom-Davis, Tom
    Janusweski, Adam
    Shah, Riyaz
    Ghosh, Sharmistha
    Hughes, Daniel Johnathan
    [J]. LUNG CANCER, 2024, 190
  • [10] Real-world analysis of haemophilia patients in China: A single centre's experience
    Song, Xuewen
    Liu, Wei
    Xue, Feng
    Zhong, Jia
    Yang, Yifan
    Liu, Yi
    Xie, Jipan
    Wu, Eric
    Zhang, Lei
    Shi, Jun
    Yang, Renchi
    [J]. HAEMOPHILIA, 2020, 26 (04) : 584 - 590
12345